Duke Robotics Corp. filings document registration-statement activity, material-event reports, governance changes, and capital-structure disclosures for the company’s robotics and drone-technology business. Its S-1 and S-1/A filings cover securities offering registration matters, while Form 8-K reports disclose corporate events and Regulation FD materials.
The company’s filings also address amendments to its articles of incorporation, including authorized common stock and blank-check preferred stock provisions, equity incentive plan share reserves, private placement terms, material agreements, shareholder voting matters, and other financing or governance disclosures.
DUKE Robotics Corp. is registering 761,905 Units, each consisting of one share of common stock and one warrant, in a firm commitment underwritten public offering. The Units are expected to be priced between $9.50 and $11.50 per Unit, with an assumed price of $10.50.
The company is also registering 170,954 existing shares of common stock for resale by selling stockholders, from which it will receive no proceeds. Net proceeds to DUKE from the primary Units offering are estimated at approximately $6.85 million, to be used for research and development, sales force expansion, marketing, business development, potential acquisitions and working capital.
The warrants in the Units are immediately exercisable at $11.55 per share and have a five‑year term, while the underwriters hold a 45‑day over‑allotment option for up to 114,286 additional shares and/or 114,286 additional warrants. Shares outstanding are expected to increase from 2,260,383 to 3,027,844 after the offering, excluding warrant and option exercises.
DUKE Robotics Corp. is registering 648,298 Units in a firm commitment public offering and 170,954 shares of common stock for resale by selling stockholders. Each Unit includes one common share and one five-year warrant exercisable at $13.57 per share, with an assumed public offering price of $12.34 per Unit, implying $8,000,000 in gross proceeds and $7,360,000 in proceeds before expenses. The company estimates net proceeds of about $6,850,000, to fund R&D, sales and marketing expansion, business development, potential acquisitions and working capital. Listing of the common stock and warrants on the Nasdaq Capital Market under “DUKR” and “DUKRW” is a condition to closing; if Nasdaq does not approve the listing, the offering will terminate. The company recently effected a 25‑for‑1 reverse stock split and develops military stabilization systems and IC Drone utility‑maintenance solutions, and warns that investing in its securities involves a high degree of risk and potential dilution.
Duke Robotics Corp. is registering 375,190 shares of common stock for resale by existing stockholders alongside a new Unit offering. The primary offering consists of firm-commitment underwritten Units, each with one common share and a five-year warrant exercisable at a percentage of the Unit price.
The company’s common stock trades on the OTCQB as “DUKR” at a last reported price of $7.86 on March 30, 2026, and Duke has applied to list its common stock and warrants on the Nasdaq Capital Market; this offering will proceed only if that listing is approved. In March 2026 it effected a 25-for-1 reverse stock split and discloses that current cash will not fund operations for 12 months, raising substantial doubt about its ability to continue as a going concern. Net proceeds from the Unit sale are intended for research and development, sales force expansion, marketing, business development, potential acquisitions and working capital, while the company will not receive proceeds from the registered resale shares.
Duke Robotics Corp. has updated its 2021 Equity Incentive Plan to clarify that a total of 480,000 shares of common stock are issuable under the plan. The share pool was previously increased by the board of directors from 192,000 to 360,000 shares and then to 480,000 shares, with the latest change approved on March 10, 2026.
DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.
Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.
DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. reported that Chief Technology Officer Maor Vadim received a grant of options to purchase 4,000 shares of common stock at an exercise price of $7.88 per share. These options are a form of equity compensation rather than an open‑market trade.
The options expire on March 10, 2032 and vest in three equal annual installments beginning on March 10, 2027. After this award, Vadim holds options for 4,000 underlying shares directly, with no sales or exercises reported in this filing.
DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.
DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.